Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.08
-12.8%
$5.06
$3.42
$7.20
$229.35M1.821.56 million shs4.79 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$1.86
-2.6%
$1.93
$1.60
$2.54
$717.37M1.041.35 million shs1.30 million shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.85
+0.2%
C$5.87
C$5.09
C$6.45
C$591.73M0.568,358 shs26,608 shs
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$16.60
$16.60
$14.90
$25.40
$141.07M1.7115,071 shsN/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-12.82%-30.26%-21.84%-8.52%-28.67%
Cronos Group Inc. stock logo
CRON
Cronos Group
-2.62%-3.63%-10.14%+3.91%-19.48%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
+0.17%-2.99%+1.56%-5.34%+7.34%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.2263 of 5 stars
0.02.00.00.01.00.80.6
Cronos Group Inc. stock logo
CRON
Cronos Group
1.559 of 5 stars
0.05.00.00.00.60.02.5
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
2.1318 of 5 stars
2.80.00.00.03.32.50.6
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00
N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.50
Strong BuyC$7.1522.22% Upside
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
2.56
Moderate Buy$16.60N/A

Current Analyst Ratings Breakdown

Latest ACB, THCX, CRON, and GUD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ BuyC$6.50
3/25/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$6.25 ➝ C$7.45
3/21/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$200.35M1.14$0.22 per share18.26$8.18 per share0.50
Cronos Group Inc. stock logo
CRON
Cronos Group
$117.61M6.10$0.00 per share3,997.25$2.90 per share0.64
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$348.70M1.70C$1.52 per share3.85C$7.65 per share0.76
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$48.62M$0.0537.099.27N/A1.32%0.13%0.10%8/6/2025 (Estimated)
Cronos Group Inc. stock logo
CRON
Cronos Group
$41.08M$0.1314.3162.0042.1839.69%-0.07%-0.07%8/6/2025 (Estimated)
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73M-C$0.30N/AN/A-8.81%-4.04%0.51%N/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Latest ACB, THCX, CRON, and GUD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/18/2025Q4 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.11$0.07-$0.04-$0.24$88.85 million$63.34 million
5/8/2025Q1 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.02+$0.01$0.02$45.44 million$33.62 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$0.724.34%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.07
3.30
1.60
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
27.80
26.75
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
7.52
3.36
1.79
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
12.58%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Cronos Group Inc. stock logo
CRON
Cronos Group
7.30%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
45.62%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,07356.21 million56.21 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450385.68 million357.53 millionOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
725101.15 millionN/ANot Optionable
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A8.50 millionN/ANot Optionable

Recent News About These Companies

Aurora Cannabis: Underappreciated Turnaround
Have Cannabis Investors Been Early Or Wrong Or Both?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.08 -0.60 (-12.82%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$4.10 +0.01 (+0.37%)
As of 06/20/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$1.86 -0.05 (-2.62%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$1.88 +0.02 (+1.29%)
As of 06/20/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$5.85 +0.01 (+0.17%)
As of 06/20/2025 04:00 PM Eastern

Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.

AXS Cannabis ETF stock logo

AXS Cannabis ETF NYSEARCA:THCX

$16.60 0.00 (0.00%)
As of 03/1/2024

The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments.